Shingles Wire
Comprehensive News Feed for Shingles.
Results 1 - 20 of 72 in Shingles
-
He thought it was an ear infection. Doc says shingles. Really? So Mr. BlahLaLa had a cold, followed by an earache that eventually got so strong and annoying he thought it was an ear infection. Comment?
-
Can the shingles vaccine prevent a recurrence?
... experts: Living Well Dear Robert: Thanks for your question. You ask about a vaccine that can help a lot of people. Shingles is a painful skin rash that occurs in older people and people who are immunosuppressed due to other diseases or treatment ... Comment?
-
Skin Care: It's Never Too Late
... that seriously impacts seniors. Dr. Spivack notes that seniors and their caregivers should consider the following: Shingles: The "Chicken Pox" of the Aging While shingles can affect anyone at any age, they are more prominent in seniors and more ... Comment?
-
Shingles vaccine: Should I get it?
... of infection, and antimicrobial resistance and therapy of bacterial infections. Treatments and drugs (1) Shingles treatment: Does alcohol use interfere with shingles therapy? Prevention (1) Shingles vaccine: Should I get it? Question Shingles ... Comment?
-
Had chickenpox? Shingles may be next
For most of his life, Barrie Morrisey only thought of shingles as part of the roof that covered his head. Comment?
-
Nearly one in three Canadians will develop shingles in their lifetime. Pain together with a rash are the red flags doctors say shouldn't be ignored. Comment?
-
For most of his life, Barrie Morrisey only thought of shingles as part of the roof that covered his house. 1 comment
-
Epiphany Announces Positive Results from Its Phase 2b Trial in Shingles.
Epiphany Biosciences announced results from its Phase 2b dose-ranging study of EPB-348 in patients with shingles infection. Comment?
-
Epiphany Announces Positive Results From Its Phase 2b Trial In Shingles
Main Category: Seniors / Aging Also Included In: Infectious Diseases / Bacteria / Viruses ; Clinical Trials / Drug Trials ; Pharma Industry / Biotech Industry Article Date: 19 Nov 2009 - 3:00 PST Epiphany Biosciences announced results from its Phase 2b dose-ranging study of EPB-348 in patients with shingles infection. Comment?
-
Epiphany Biosciences announces positive results from phase IIb trial in shingles
... announced today results from its Phase IIb dose-ranging study of EPB-348 (valomaciclovir) in patients with shingles (herpes zoster) infection. EPB-348 is a potent inhibitor of herpes viruses, including the varicella zoster and Epstein-Barr viruses ... Comment?
-
FDA Approves New Drug For Pain That Persists After Shingles
... an often excruciating pain that can persist for weeks, months and even years in 10 to 15 per cent of people who get shingles . The medicated skin patch, which is made by Lohmann Therapie-Systems AD of Andernach, Germany and distributed in the US by ... Comment?
-
What is Postherpetic Neuralgia?
The pain remaining after an acute episode of shingles is called postherpetic neuralgia . Comment?
-
Qutenza Approved for Post-Shingles Nerve Pain
The Qutenza skin patch has been approved by the U.S. Food and Drug Administration to treat pain due to postherpetic neuralgia , the nerve pain that may follow shingles, drug maker NeurogesX said in a news release. Comment?
-
Epiphany Biosciences announces results from its valomaciclovir Phase 2b trial for shingles
Epiphany Biosciences announced results from its Phase 2b dose-ranging study of EPB-348 in patients with shingles infection. Comment?
-
NeurogesX wins FDA approval of pain patch
NeurogesX Inc. won approval for its Qutenza patch to treat shingles-related pain. Comment?
-
What is Shingles and What Will Help?
Shingles, also known as herpes zoster, is the skin rash as a result of a virus.A This virus, Varicella zoster virus, is also the same virus that causes chickenpox.A When a person contracts chickenpox and it has cleared it does not fully go away, but stays within you. Comment?
-
... or magic? While there have been reports and claims that aromatherapy can be beneficial in improving symptoms of shingles, fighting staph infections, such as E.coli and MRSA, or even preventing or treating cancers, there is no scientific evidence to ... Comment?
-
FDA pushes back review of GlaxoSmithKline treatment for shingles
Get the latest news alerts: Follow LTW at Twitter. Local Tech Wire RESEARCH TRIANGLE PARK, N.C. The U.S. Food and Drug Administration has pushed back its delay of a proposed treatment for shingles that is being developed by GlaxoSmithKline and California-based XenoPort. Comment?
-
Inaccurate Statement in: A 70-Year-Old Woman With Shingles [Correction]
... and what you can do to make your experience on this site better. Inaccurate Statement in: A 70-Year-Old Woman With Shingles JAMA. 2009;302(17):1864. Inaccurate Statement: In the Clinical Crossroads entitled "A 70-Year-Old Woman With Shingles" ... Comment?
-
Each year more than one million people in the U.S. suffer an outbreak of shingles, a blistering rash caused by the same virus that causes chickenpox. Comment?
Shingles Forum
Most Popular
- A bleak future for black children and youth - 413 comments
- Shame On Me For Voting For Obama - 327 comments
- PolitiFact's Lie of the Year: 'Death panels' - 466 comments
- Angels can't fly, scientist says - 110 comments
- TV talent show exposes China's race issue - 129 comments
- Man fatally shot in Berwyn - 147 comments
- McCain: Try sanctions first against Iran - 85 comments
- Israeli Occupation, Colonialism and Apartheid - 369 comments
- 911? My son won't stop playing video games - 67 comments
- Yes, China Is an Economic Superpower - 153 comments
|
Reach local customers. Engage a specific demographic. Maximize business-to-business opportunities. Topix can deliver your message.
|
Copyright ©2009 Topix LLC
